Case reports provide valuable insights into rare malignancies, unusual disease presentations, diagnostic challenges, unexpected responses, and complex treatment decisions. This session offers a platform for sharing clinically important observations that can contribute to learning, hypothesis generation, and improved cancer management.
Abstract Scope and Participation
Submissions may include rare cancer cases, unusual clinical presentations, diagnostic challenges, novel treatment approaches, exceptional responses, treatment complications, multidisciplinary management, and other educational cases. Clinicians, researchers, trainees, nurses, and healthcare professionals involved in cancer care are encouraged to contribute.
Primary intraocular lymphomas (PIOL) or vitreoretinal lymphomas (VRL) are a type of primary central nervous system lymphoma (PCNSL), accounting for approximately 2–3% of all non-Hodgkin lymphomas and…
Immune checkpoint inhibitors have marked a new era in contemporary cancer therapy. However, they are associated with a spectrum of immune-related adverse events (irAEs), including rare but severe…
Homoeopathy is an alternative system of medicine discovered by German physician Samuel Hahnemann in 1796. It has been used by several people for various health conditions globally for more than last…
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Oral and poster slots for original Cancer Case Reports work, reviewed by the scientific committee.
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Plenary lectures from leading voices shaping Cancer Case Reports research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Cancer Case Reports track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer Case Reports. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Cancer researchers and clinicians, educators and students with an interest in Cancer Case Reports are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. CIOC 2027 is a hybrid conference — attend the Cancer Case Reports track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
